This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (27) Citing Articles via Google Scholar Google Scholar Articles by Adabag, A. S. Articles by Maron, M. S. Search for Related Content PubMed Articles by Adabag, A. S. Articles by Maron, M. S. Related Collections Related Articles

CLINICAL RESEARCH: HYPERTROPHIC CARDIOMYOPATHY

Occurrence and Frequency of Arrhythmias in Hypertrophic Cardiomyopathy in Relation to Delayed Enhancement on Cardiovascular Magnetic Resonance

A. Selcuk Adabag, MD, MS^_*,_*, Barry J. Maron, MD, Evan Appelbaum, MD^,, Caitlin J. Harrigan, BA, Jacqueline L. Buros, BA, C. Michael Gibson, MD, MS^,, John R. Lesser, MD, Constance A. Hanna, RN, James E. Udelson, MD^||, Warren J. Manning, MD^, and Martin S. Maron, MD^||

^_* Division of Cardiology, Veterans Affairs Medical Center, Minneapolis, Minnesota
Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, Minneapolis, Minnesota
Cardiovascular Division, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts
PERFUSE Core Laboratory and Data Coordinating Center, Harvard Medical School, Boston, Massachusetts
^|| Hypertrophic Cardiomyopathy Center, Division of Cardiology, Tufts-New England Medical Center, Boston, Massachusetts.

Manuscript received August 2, 2007; revised manuscript received November 2, 2007, accepted November 26, 2007.

^_* Reprint requests and correspondence: Dr. A. Selcuk Adabag, Section of Cardiology (111 C), Veterans Affairs Medical Center, One Veterans Drive, Minneapolis, Minnesota 55417. (Email: adaba001{at}umn.edu).

Objectives: Our aim was to determine whether myocardial fibrosis, detected by cardiovascular magnetic resonance (CMR), represents an arrhythmogenic substrate in hypertrophic cardiomyopathy (HCM).

Background: Myocardial fibrosis is identified frequently in HCM; however, the clinical significance of this finding is uncertain.

Methods: We studied prevalence and frequency of tachyarrhythmias on 24-h ambulatory Holter electrocardiogram (ECG) with regard to delayed enhancement (DE) on contrast-enhanced CMR in 177 HCM patients (age 41 ± 16 yrs; 95% asymptomatic or mildly symptomatic).

Results: Premature ventricular contractions (PVCs), couplets, and nonsustained ventricular tachycardia (NSVT) were more common in patients with DE than those without DE (PVCs: 89% vs. 72%; couplets: 40% vs. 17%; NSVT: 28% vs. 4%; p < 0.0001 to 0.007). Patients with DE also had greater numbers of PVCs (202 ± 655 vs. 116 ± 435), couplets (1.9 ± 5 vs. 1.2 ± 10), and NSVT runs (0.4 ± 0.8 vs. 0.06 ± 0.4) than non-DE patients (all p < 0.0001); DE was an independent predictor of NSVT (relative risk 7.3, 95% confidence interval 2.6 to 20.4; p < 0.0001). However, extent (%) of DE was similar in patients with and without PVCs (8.2% vs. 9.1%; p = 0.93), couplets (8.5% vs. 8.4%; p = 0.99), or NSVT (8.3% vs. 8.5%; p = 0.35).

Conclusions: In this large HCM cohort with no or only mild symptoms, myocardial fibrosis detected by CMR was associated with greater likelihood and increased frequency of ventricular tachyarrhythmias (including NSVT) on ambulatory Holter ECG. Therefore, contrast-enhanced CMR identifies HCM patients with increased susceptibility to ventricular tachyarrhythmias.

Abbreviations and Acronyms   CMR = cardiovascular magnetic resonance   DE = delayed enhancement   ECG = electrocardiogram   HCM = hypertrophic cardiomyopathy   ICD = implantable cardioverter-defibrillator   LV = left ventricular/ventricle   NSVT = nonsustained ventricular tachycardia   PVC = premature ventricular contraction   ROC = receiver-operating characteristic   SVT = supraventricular tachycardia

Related Articles

Cardiovascular Magnetic Resonance for Risk Stratification of Arrhythmia in Hypertrophic Cardiomyopathy

Saman Nazarian and João A.C. Lima
J. Am. Coll. Cardiol. 2008 51: 1375-1376. [Full Text] [PDF]

This article has been cited by other articles:

				S. Leonardi, C. Raineri, G. M. De Ferrari, S. Ghio, L. Scelsi, M. Pasotti, M. Tagliani, A. Valentini, R. Dore, A. Raisaro, et al. Usefulness of cardiac magnetic resonance in assessing the risk of ventricular arrhythmias and sudden death in patients with hypertrophic cardiomyopathy Eur. Heart J., May 27, 2009; (2009) ehp152v1. [Abstract] [Full Text] [PDF]

				D. Wang, V. V. Patel, E. Ricciotti, R. Zhou, M. D. Levin, E. Gao, Z. Yu, V. A. Ferrari, M. M. Lu, J. Xu, et al. Cardiomyocyte cyclooxygenase-2 influences cardiac rhythm and function PNAS, May 5, 2009; 106(18): 7548 - 7552. [Abstract] [Full Text] [PDF]

				A. S. Flett, M. A. Westwood, L. C. Davies, A. Mathur, and J. C. Moon The Prognostic Implications of Cardiovascular Magnetic Resonance Circ Cardiovasc Imaging, May 1, 2009; 2(3): 243 - 250. [Full Text] [PDF]

				L. F. Tops and J. J. Bax The Year in Imaging Related to Electrophysiology J. Am. Coll. Cardiol. Img., April 1, 2009; 2(4): 498 - 510. [Full Text] [PDF]

				F Alpendurada, J Wong, and D J Pennell Practical applications of cardiovascular magnetic resonance Heart Asia, March 31, 2009; 2009(3): 16 - 22. [Abstract] [Full Text] [PDF]

				A. La Gerche, A. J. Taylor, and D. L. Prior Athlete's Heart: The Potential for Multimodality Imaging to Address the Critical Remaining Questions. J. Am. Coll. Cardiol. Img., March 1, 2009; 2(3): 350 - 363. [Abstract] [Full Text] [PDF]

				A. Attili, G. C. Mueller, and S. M. Day AJR Teaching File: Asymptomatic Man with Giant Negative T Waves on ECG Am. J. Roentgenol., March 1, 2009; 192(3_Supplement): S57 - S61. [Full Text] [PDF]

				S. Nazarian, D. A. Bluemke, and H. R. Halperin Applications of Cardiac Magnetic Resonance in Electrophysiology Circ Arrhythmia Electrophysiol, February 1, 2009; 2(1): 63 - 71. [Full Text] [PDF]

				A. N. DeMaria, O. Ben-Yehuda, J. J. Bax, G. K. Feld, B. H. Greenberg, W. Y.W. Lew, J. A.C. Lima, A. S. Maisel, S. M. Narayan, D. J. Sahn, et al. Highlights of the Year in JACC 2008. J. Am. Coll. Cardiol., January 27, 2009; 53(4): 373 - 398. [Full Text] [PDF]

				A. Rudolph, H. Abdel-Aty, S. Bohl, P. Boye, A. Zagrosek, R. Dietz, and J. Schulz-Menger Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling. J. Am. Coll. Cardiol., January 20, 2009; 53(3): 284 - 291. [Abstract] [Full Text] [PDF]

				M. L. Chuang and W. J. Manning Left ventricular hypertrophy and excess cardiovascular mortality is late gadolinium enhancement the imaging link? J. Am. Coll. Cardiol., January 20, 2009; 53(3): 292 - 294. [Full Text] [PDF]

				M. S. Maron, J. J. Finley, J. M. Bos, T. H. Hauser, W. J. Manning, T. S. Haas, J. R. Lesser, J. E. Udelson, M. J. Ackerman, and B. J. Maron Prevalence, Clinical Significance, and Natural History of Left Ventricular Apical Aneurysms in Hypertrophic Cardiomyopathy Circulation, October 7, 2008; 118(15): 1541 - 1549. [Abstract] [Full Text] [PDF]

				P Elliott and P Spirito Prevention of hypertrophic cardiomyopathy-related deaths: theory and practice Heart, October 1, 2008; 94(10): 1269 - 1275. [Abstract] [Full Text] [PDF]

				A. Dhoble, S. R. Punnam, and G. S. Abela Likelihood of Ventricular Arrhythmias Due to Myocardial Fibrosis in Hypertrophic Cardiomyopathy as Detected by Cardiac Magnetic Resonance Imaging J. Am. Coll. Cardiol., September 9, 2008; 52(11): 969 - 969. [Full Text] [PDF]

				A. S. Adabag, B. J. Maron, E. Appelbaum, C. J. Harrigan, J. L. Buros, C. M. Gibson, J. R. Lesser, C. A. Hanna, J. E. Udelson, W. J. Manning, et al. Reply J. Am. Coll. Cardiol., September 9, 2008; 52(11): 969 - 970. [Full Text] [PDF]

				N. Reichek and D. Gupta Hypertrophic Cardiomyopathy: Cardiac Magnetic Resonance Imaging Changes the Paradigm J. Am. Coll. Cardiol., August 12, 2008; 52(7): 567 - 568. [Full Text] [PDF]

				S. Nazarian and J. A.C. Lima Cardiovascular Magnetic Resonance for Risk Stratification of Arrhythmia in Hypertrophic Cardiomyopathy J. Am. Coll. Cardiol., April 8, 2008; 51(14): 1375 - 1376. [Full Text] [PDF]